Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced that the first patients have been enrolled in two global Phase III clinical trials — MINT-E (NCT07018700 ...

Teva offers strong value upside through disciplined execution and does not require growth surprise. Read more on TEVA stock ...

Discussion of ten common requests received in Gynaecology advice and guidance service and explain how these are managed ...

Cleveland Clinic Cole Eye Institute researchers have identified a potential association between the use of GLP-1 receptor agonist (GLP-1RA) therapy and a reduced risk of non-infectious uveitis, a type ...

The U.S. Food and Drug Administration has approved an injectable version of Eisai and Biogen's Alzheimer's disease drug Leqembi, the companies said on Friday, allowing for an easier treatment option ...

The researchers used insulin as a model because it’s a highly sought-after and expensive drug with lots of well-established ...

Eisai Co. and Biogen Inc. received US regulatory approval for a new self-injected form of their Alzheimer’s drug Leqembi, in ...

Ideas of fitness being built around eating less and exercising more are being upended by drugs such as Wegovy and Ozempic.

Most US neurologists treating patients with multiple sclerosis receive industry payments, with higher payments linked to higher prescribing of that company’s drugs, new research shows.

When headaches or sore muscles strike us at home, we reach for everyday painkillers. Usually it’s something like ibuprofen, ...

LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat ...

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...